Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oric Pharmaceuticals, Inc. - Common Stock
(NQ:
ORIC
)
8.360
+0.090 (+1.09%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oric Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
March 21, 2023
Via
Benzinga
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
March 16, 2023
From
ORIC Pharmaceuticals
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
March 16, 2023
Via
Benzinga
ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting
March 14, 2023
From
ORIC Pharmaceuticals
Via
GlobeNewswire
ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference
March 06, 2023
From
ORIC Pharmaceuticals
Via
GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 03, 2023
From
ORIC Pharmaceuticals
Via
GlobeNewswire
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
February 01, 2023
From
ORIC Pharmaceuticals
Via
GlobeNewswire
7 Top Short-Squeeze Candidates to Watch in February
February 01, 2023
For those that want to zig while others zag, these heavily targeted stocks represent the top short-squeeze candidates to watch this month.
Via
InvestorPlace
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
January 09, 2023
From
ORIC Pharmaceuticals
Via
GlobeNewswire
ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
ORIC Pharmaceuticals
Via
GlobeNewswire
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 23, 2022
Via
Benzinga
US Stocks Open Lower; Dow Falls Over 100 Points
December 23, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Friday.
Via
Benzinga
Dow Dips 600 Points; AMC Entertainment Shares Plunge
December 22, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 600 points on Thursday.
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 22, 2022
Via
Benzinga
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher
December 22, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday.
Via
Benzinga
CENN Stock Alert: Cenntro Electric Receives EPA Certification
December 22, 2022
Cenntro Electric (CENN) stock is on the move Thursday as investors react to the EPA granting a Certificate of Conformity to the company.
Via
InvestorPlace
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3
December 22, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday.
Via
Benzinga
ORIC Pharmaceuticals (ORIC) Stock Rockets 58% on Pfizer Deal
December 22, 2022
ORIC Pharmaceuticals (ORIC) stock is rocketing higher after the company revealed a collaboration agreement with Pfizer (PFE).
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 22, 2022
Via
Benzinga
ORIC Pharmaceuticals Shares Move Higher After Equity Infusion, Clinical Collaboration From Pfizer
December 22, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 22, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Thursday!
Via
InvestorPlace
Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer
December 21, 2022
From
ORIC Pharmaceuticals
Via
GlobeNewswire
ORIC Pharmaceuticals Presents Preclinical Data Demonstrating ORIC-533 as a Potential Best-in-Class CD73 Inhibitor at the 64th American Society of Hematology (ASH) Annual Meeting
December 13, 2022
From
ORIC Pharmaceuticals
Via
GlobeNewswire
ORIC Pharmaceuticals to Present at the Jefferies London Healthcare Conference
November 08, 2022
From
ORIC Pharmaceuticals
Via
GlobeNewswire
ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update
November 07, 2022
From
ORIC Pharmaceuticals
Via
GlobeNewswire
ORIC Pharmaceuticals to Present Preclinical Data on CD73 Inhibitor Program in Multiple Myeloma at the 64th American Society of Hematology (ASH) Annual Meeting
November 03, 2022
From
ORIC Pharmaceuticals
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
November 04, 2022
Friday's session saw 236 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.